#Telmisartan

[verdantpharma]

CAS NO 144701-48-4 (TELMISARTAN)

Understanding Telmisartan: A Comprehensive Guide to CAS Number 144701-48-4

Telmisartan, with the Chemical Abstracts Service CAS number 144701-48-4, is a widely prescribed medication primarily used for managing high blood pressure (hypertension) and protecting the kidneys in patients with type 2 diabetes. It belongs to a class of drugs known as angiotensin II receptor antagonists (ARBs), which work by blocking the action of a hormone called angiotensin II. This hormone typically causes blood vessels to constrict, leading to increased blood pressure. By inhibiting this action, Telmisartan helps lower blood pressure and improves overall cardiovascular health.

Chemical Structure and Properties

Telmisartan is an organic compound with the molecular formula C20H18N4O3. Its structure consists of a benzimidazole ring system fused to a tetrazole ring, making it part of a broader group of sartans. This specific configuration allows Telmisartan to bind effectively to the angiotensin II type 1 receptor (AT1), which is responsible for the majority of the effects of angiotensin II on blood pressure regulation.

Some key properties of Telmisartan include:

Molecular weight: 514.39 g/mol

Solubility: Practically insoluble in water but soluble in organic solvents like methanol and dimethyl sulfoxide (DMSO).

Chemical Name: 4'-(2-(4-(2-(1H-tetrazol-5-yl)-phenyl)-thiazol-5-yl)-phenyl) thiazol-2-yl)-[1,1'-biphenyl]-4-carboxylic acid.

This structure contributes to its long half-life, which allows it to be taken once a day.

Mechanism of Action

Telmisartan works by blocking the action of angiotensin II, a potent vasoconstrictor that can elevate blood pressure. The drug specifically targets the angiotensin II type 1 receptor (AT1). By binding to this receptor, Telmisartan prevents angiotensin II from exerting its effects, which include narrowing blood vessels, increasing sodium reabsorption by the kidneys, and stimulating the release of aldosterone. The result is vasodilation (widening of blood vessels), reduced blood pressure, and decreased strain on the heart.

Benefits and Uses of Telmisartan

Telmisartan is primarily prescribed for the treatment of hypertension. However, it has several additional uses and benefits:

Hypertension (High Blood Pressure): Telmisartan helps to reduce high blood pressure, which lowers the risk of heart attack, stroke, and kidney problems. By relaxing blood vessels, it eases the workload on the heart and promotes better circulation.

Cardiovascular Protection: It has been shown to reduce the risk of heart attack and stroke in individuals with existing cardiovascular diseases, improving long-term outcomes for patients at risk.

Renal Protection in Diabetic Nephropathy: In patients with type 2 diabetes, Telmisartan can protect against kidney damage (nephropathy) by reducing proteinuria (the presence of excess protein in the urine) and slowing the progression of kidney disease.

Reduction in Risk of Cardiovascular Events: Studies suggest that Telmisartan can lower the risk of major cardiovascular events, especially in high-risk individuals, due to its beneficial effects on blood pressure and overall vascular health.

Dosage and Administration

Telmisartan is usually administered orally, in the form of tablets, and is typically available in 20 mg, 40 mg, and 80 mg dosages. The recommended starting dose for most individuals is 40 mg once a day. However, depending on the patient's condition, this dose may be increased to 80 mg per day.

It’s important for individuals on Telmisartan to follow their healthcare provider's instructions carefully, as dosage adjustments may be needed based on blood pressure readings or kidney function.

Side Effects and Precautions

Like any medication, Telmisartan can cause side effects, although not everyone will experience them. Common side effects include:

Dizziness or lightheadedness, especially when standing up quickly.

Headache and fatigue.

Elevated potassium levels (hyperkalemia), which can cause irregular heartbeats and muscle weakness.

Low blood pressure (hypotension), especially in those who are also taking other antihypertensive medications.

Serious but rare side effects can include:

Angioedema, a condition where swelling occurs in the face, lips, tongue, or throat, which can be life-threatening if it obstructs the airways.

Liver or kidney problems, particularly in patients with pre-existing kidney disease.

Patients should avoid taking Telmisartan if they are pregnant or planning to become pregnant, as it can cause harm to the developing fetus. It is also important for individuals with a history of renal artery stenosis or severe liver disease to inform their healthcare provider before starting treatment.

Drug Interactions

Telmisartan may interact with other medications, including:

Other antihypertensive drugs (e.g., diuretics, ACE inhibitors, or calcium channel blockers), which can enhance the blood-pressure-lowering effects and potentially cause low blood pressure.

Lithium, as the combination with Telmisartan can increase the risk of lithium toxicity.

Nonsteroidal anti-inflammatory drugs (NSAIDs), which may reduce the effectiveness of Telmisartan in lowering blood pressure and increase the risk of kidney damage.

Conclusion

Telmisartan (CAS No. 144701-48-4) is a highly effective medication for managing high blood pressure and providing protection against cardiovascular and renal complications. As an angiotensin II receptor antagonist, it offers long-lasting control of hypertension with a relatively favorable side-effect profile. However, like any medication, its use should be monitored by a healthcare provider, especially in patients with underlying conditions or those taking multiple medications.

If you or someone you know is considering Telmisartan for managing high blood pressure or other related conditions, it's essential to have a discussion with a healthcare provider to determine if this treatment is appropriate based on individual health needs.

URL: For more information, visit Verdant Pharma : CAS number 144701-48-4 Telmisartan

[digitalsanskrutipractise]

Telmisartan Impurity | Allmpus

Allmpus Lab offers expert analysis of Telmisartan impurities, providing precise identification, quantification, and management solutions. Ensure the purity and compliance of your Telmisartan products with our advanced testing and consultancy services. Trust Allmpus Lab for reliable results and professional guidance on managing Telmisartan-related contaminants.

Allmpus Laboratories Pvt Ltd

Contact Us :8655752646

[numeralifesciences441]

Telmisartan 40 mg + Hydrochlorothiazide 12.5 mg Franchise | Telmisartan 40 mg + Hydrochlorothiazide 12.5 mg PCD Pharma Company

Telmisartan 40 mg + Hydrochlorothiazide 12.5 mg - Telmisartan belongs to a group of drugs called angiotensin regulator blockers (ARBs). It is used to lower blood pressure and prevent strokes in high blood pressure patients. Hydrochlorothiazide, a prescription medication, is part of a group of drugs known as thiazide-diuretics. It is used to lower blood pressure and prevent strokes in high blood pressure patients. You can open a franchise for Telmisartan 40mg + Hydrochlorothiazide 12 mg tablets with Numera Lifescience if you're new to the pharma industry.

[megpricephotography]

For those who're following Flynn's health problems… update is below the cut. Not a great one, sadly.

We went back to the vets on Fri 31st Jan. Flynn had been on his new medicine - telmisartan - for 2 weeks. He's taking it in an effort to reduce the "leakiness" of his remaining kidney. I'd collected a sample for urinalysis a couple of days prior & we got blood taken on the day. Vet spoke to me Sat morning.

I'll start with the positives. Flynn's weight is still good. Actually, at any other time, I'd say he was actively too chubby but I've been intentionally stuffing his face with as much kidney-safe food as he'll eat & it's good he's heavy & good he's managed to gain a bit. As for blood work - Flynn's blood count is good, he isn't anaemic (a worry), electrolytes are normal.

However.

Urinalysis… unfortunately, Flynn's protein loss in his pee is sky high & still maxing out their machine. I wasn't shocked by this result, as telmisartan can take a bit of time to fully work & have an effect… & Flynn's only on a 1/2 dose for his weight. Still, I was obviously hoping for better news. I wish we could at least tell if we're heading in the right direction or not.

Blood work. Urgh. Sadly Flynn's now in Stage 2 of Chronic Kidney Disease. Technically, Stage 2 CKD is considered relatively "mild" & often manageable for a considerable length of time. The worry though, is that Flynn's kidney function seems to be deteriorating pretty fast. From what I've read, this isn't uncommon in dogs who've had high protein levels in their urine, plus, again: Flynn is down 1 kidney… Also, we're already doing what we can to support his kidney, & currently it doesn't seem to be helping much, if at all. Vet's previously said he fears Flynn's kidney has just sort of... reached the limit of what it can cope with.

For now, we're keeping Flynn on a 1/2 dose of telmisartan. Yes, we could increase it but telmisartan can cause side-effects (we're seeing some), including even kidney damage (tbh, I am worried it may be harming not helping… but then again, Flynn has seemed better able to keep weight on since taking meds so, who knows). Vet & I are concerned a full dose could be too much for Flynn to tolerate. We'll monitor, may increase the dose… may take him off it entirely. We are going to add a phosphate binder to his food, which can help maintain kidney function. Flynn's been on a renal diet for 18+ months. Some dogs with his symptoms are put on immunosuppressants, but my vet hasn't brought it up as an option & tbh, I'd be concerned about potential side-effects, although I may look into it more.

As for Flynn… eh, he's OK, for now… mostly, I think? He's sweet & wanting gentle pats, so I don't think he's hugely sore, or distressed. He's feeling sick at times (picky about food) but not sure if it's telmisartan or kidney disease. He's definitely tired & quiet & wanting to be home, warm. That's fine. We get out once or twice a day for a short walk, & he still seems interested in things. I've pulled old Barney's buggy out & started encouraging Flynn to hop in, for if/when he's at a point of wanting to go out but not walk far at all. Obviously, I am still very much trying to hold onto hope we can get him stabilised & keep him happy for some time to come but gosh it's hard & I am struggling to be overly optimistic. I guess all we can do is take each day as it comes.

Sorry for the long read, partly this is for me... I find it helps writing stuff down. Hug your dogs, guys & please think good thoughts for Flynnie.

[aingopharma]

Take Control of Hypertension with TELSWIT-40 by Aingo Pharma Pvt. Ltd. 🌟 💊 40 mg Telmisartan for safe and effective blood pressure management 💡 Supports overall cardiovascular health 🩺 Follow your healthcare provider’s guidance for optimal results Prioritize your well-being today! 💖 ………………………………………………….. ✅ WHO / ISO / GMP certified Products ✅ 150+ PRODUCTS ✅ TIMELY DELIVERY ………………………………………………….. If you are interested, Contact us : Call us : +91-82880-84022 Website :www.aingopharma.co.in Email : aingopharma@gmail.com …………………………………………………..

[credenceresearchdotblog]

The global Telmisartan Market is projected to grow from USD 3,705 million in 2024 to USD 4,444.19 million by 2032, at a modest compound annual growth rate (CAGR) of 2.3% over the forecast period. The Telmisartan market has witnessed substantial growth over the past few years, driven by increasing prevalence of cardiovascular diseases (CVDs), hypertension, and a growing awareness about the benefits of angiotensin receptor blockers (ARBs). As a widely used antihypertensive drug, Telmisartan is favored for its efficacy, long duration of action, and tolerability. This article delves into the market dynamics, growth factors, challenges, and the future outlook for the Telmisartan market.

Browse the full report at https://www.credenceresearch.com/report/telmisartan-market

Understanding Telmisartan and Its Role

Telmisartan is an ARB primarily prescribed for managing hypertension and reducing cardiovascular risks in patients. It works by blocking the action of angiotensin II, a hormone that causes blood vessels to constrict, thus lowering blood pressure and improving heart health. Its unique pharmacokinetic profile, which allows once-daily dosing, has made it a preferred choice among both physicians and patients.

Market Drivers

Rising Incidence of Hypertension According to the World Health Organization (WHO), hypertension affects over 1.2 billion people globally, making it one of the leading causes of premature death. The increasing prevalence of sedentary lifestyles, unhealthy diets, and stress has significantly contributed to the rise in hypertension cases, thereby driving demand for effective antihypertensive medications like Telmisartan.

Growing Awareness of Cardiovascular Health Public health initiatives and awareness campaigns have educated individuals about the importance of managing hypertension and preventing cardiovascular diseases. This has led to an uptick in regular health check-ups and early diagnosis, increasing the demand for antihypertensive drugs.

Generic Drug Availability The expiration of patents for branded Telmisartan formulations has led to a surge in generic versions, making the drug more accessible and affordable, particularly in emerging markets. This has played a crucial role in market expansion.

Aging Population The global aging population is another critical factor driving the Telmisartan market. Older adults are more prone to hypertension and related complications, creating a sustained demand for effective treatments.

Market Challenges

Side Effects and Contraindications Although Telmisartan is generally well-tolerated, potential side effects such as dizziness, hyperkalemia, and renal impairment in certain patient groups can limit its widespread use.

Competition from Alternative Therapies The market faces competition from other classes of antihypertensive drugs, including ACE inhibitors, calcium channel blockers, and beta-blockers. Additionally, newer therapies with advanced mechanisms of action may challenge Telmisartan's market position.

Regulatory Hurdles Stringent regulatory requirements for approval and periodic safety updates can pose challenges for manufacturers, especially in regions with complex compliance norms.

Future Outlook

The Telmisartan market is poised for sustained growth in the coming years, driven by:

Technological Advancements: Ongoing research into combination therapies involving Telmisartan is expected to broaden its clinical applications and enhance treatment outcomes.

Expanding Generic Penetration: As more generic versions enter the market, affordability and accessibility will improve, especially in low- and middle-income countries.

Increased Focus on Preventive Healthcare: Governments and healthcare organizations are emphasizing preventive measures for chronic diseases, which is likely to boost Telmisartan's uptake.

Key Player Analysis:

Boehringer Ingelheim GmbH

Mylan N.V.

Teva Pharmaceutical Industries Ltd.

Abbott Laboratories

Cipla Inc.

Aurobindo Pharma Ltd.

Macleods Pharmaceuticals Ltd.

Sun Pharmaceutical Industries Ltd.

Lupin Limited

Zydus Cadila

Segmentations:

By Composition

Single

Combinational

By Indication

Hypertension

Nephropathy

Hepatorenal Syndrome

Cardiac Arrest

Stroke

By Dosage Form

Tablets

Capsules

Injection

Oral suspension

By Distribution Channel

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

 By Region          

North America

U.S.

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

South-east Asia

Rest of Asia Pacific

Latin America

Brazil

Argentina

Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

Rest of the Middle East and Africa

Browse the full report at https://www.credenceresearch.com/report/telmisartan-market

About Us:

Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: sales@credenceresearch.com 

[advikpharma]

Telmisartan Tablets - Effective Blood Pressure Management

Learn about the advantages of using Telmisartan Tablets, a dependable treatment for hypertension. Telmisartan supports heart health over the long run by reducing the risk of cardiovascular events. Our Telmisartan Tablets, which are produced by Advik Pharma, are of the greatest quality and efficacy, meeting all pharmaceutical criteria.

Telmisartan Tablets

[platinumpharmacy]

Cilacar T Tablet: Uses, Dosage, Side Effects, and More

Cilacar T Tablet is a medication that is commonly prescribed to help manage various cardiovascular conditions. This article aims to provide an in-depth overview of Cilacar T Tablet, including its uses, dosage guidelines, potential side effects, and other essential information for those considering or currently using this medication.

What is Cilacar T Tablet?

Cilacar T Tablet is a combination medication that typically contains two active ingredients: Cilnidipine and Telmisartan. Cilnidipine belongs to the class of calcium channel blockers, while Telmisartan is an angiotensin receptor blocker (ARB). This combination is often prescribed to treat hypertension (high blood pressure) and other cardiovascular conditions.

Uses of Cilacar T Tablet

Hypertension: Cilacar T Tablet is primarily used to lower blood pressure in patients with hypertension. The combination of Cilnidipine and Telmisartan helps relax blood vessels, making it easier for the heart to pump blood and reducing the workload on the heart.

Cardiovascular Protection: In addition to managing high blood pressure, Cilacar T Tablet may also offer cardiovascular protection by reducing the risk of heart-related complications in patients with underlying heart conditions.

Dosage and Administration

Dosage: The dosage of Cilacar T Tablet can vary based on individual factors such as the patient's age, medical condition, and response to treatment. It is crucial to follow the dosage instructions provided by your healthcare provider.

Administration: Cilacar T Tablet is typically taken orally with or without food. It is essential to swallow the tablet whole with a glass of water and not crush or chew it unless advised otherwise by your doctor.

Possible Side Effects

Like any medication, Cilacar T Tablet may cause side effects in some individuals. Common side effects associated with this medication may include:

Dizziness

Headache

Fatigue

Swelling of the ankles or feet

Nausea or vomiting

Muscle pain

It is essential to consult your healthcare provider if you experience any persistent or severe side effects while taking Cilacar T Tablet.

Precautions and Warnings

Before starting Cilacar T Tablet, inform your healthcare provider about any existing medical conditions, allergies, or medications you are currently taking. Additionally, consider the following precautions:

Avoid consuming alcohol while taking Cilacar T Tablet, as it may increase the risk of side effects.

Inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding before using this medication.

Regular monitoring of blood pressure and kidney function may be necessary while taking Cilacar T Tablet.

Conclusion

Cilacar T Tablet is a combination medication used to manage hypertension and provide cardiovascular protection. While it can be effective in controlling blood pressure and reducing the risk of heart-related complications, it is essential to follow your healthcare provider's recommendations regarding dosage, administration, and monitoring. If you experience any concerning side effects or have questions about Cilacar T Tablet, consult your doctor promptly for guidance and appropriate management.

[schlauemaus]

Chronische Niereninsuffizienz (Ktz)

= progressiver und irreversibler Verlust der Nierenfunktion

Urinkonzentrierungsfähigkeit sinkt, wenn 2/3 aller Nephrone in beiden Nieren nicht mehr funktionieren -> wenn mehr als 3/4 nicht mehr funktionieren, kommt es zur Azotämie

Prävalenz steigt mit dem Alter, es sind AKUTE SCHÜBE möglich

Ursachen

tubulointerstitiell: Nephropathien ((Pyelo)Nephritis, Tumor, Amyloidose, Zysten)

vaskulär: Bluthochdruck

glomerulär: Glomerulonephritis, Glomerulosklerose

Sammelröhrchen/ Nierenbecken: Nierensteine, Hydronephrose

-> meistens chron. interstitielle Nephritis -> Funktionsverlust einzelner Nephrone -> Kompensation: Hypertrophie der anderen Nephrone -> intraglomuläre Hypertension und Hyperfiltration -> weitere Nierenschädigung und GFR Reduktion

GFR= Glomeruläre Filtrationsrate= Menge, die pro Zeiteinheit durch die Nierenkörperchen filtriert wird= Bildungsrate des Primärharns

Symptome

Anorexie, Gewichtsabnahme, Lethargie

Polyurie/Polydipsie (weil Nieren nicht mehr konzentrationsfähig; bei Ktz grundsätzlich seltener als bei Hd) -> verminderte Hautelastizität/ Dehydrierung -> Inappetenz, Schwäche, Obstipation

blasse Schleimhäute (wg. Anämie (wg. verminderter EPO-Produktion, gastrointest. Blutungen, kürzere Ery.-Lebenszeit))

Bluthochdruck (wg. fibrosierten glomerulären Gefäßen, verminderter Prostaglandinausschüttung (wirkt gefäßerweiternd), Aktivierung Renin-Angiotensin-System) -> Augenveränderungen (Retinopathien), neurologische Symptome

Nieren bei Palpation zu groß od. klein, Oberfläche ev. nicht glatt, ev. schmerzhaft

Komplikationen wg. Urämie (= zu viele harnpflichtige Substanzen im Blut) zB Gingivitis mit oralen Läsionen/ lockeren Zähnen/ Foetor ex ore; Herzarrhythmien; Inappetenz, Erbrechen

Hyperparathyreoidismus (sekundär, renal bedingt)

Diagnose

Harnuntersuchung:

niedriges spezifisches Gewicht (<1035) Proteinurie (prä-, post- od. renal?) Bakteriurie, je nach Ursache möglich

Blutuntersuchung:

normochrome, normozytäre, nicht-regenerative Anämie Azotämie (Harnstoff u. Kreatinin erhöht) -> prä-, post- oder renal? erhöhtes SDMA (=symmetrisches Dimethylarginin) Hyperphosphatämie (wenn GFR um 20% gesunken ist, wird weniger Phosphor rausfiltriert) Entzündungsleukogramm, je nach Ursache möglich

Bildgebung:

Nieren zu klein/groß Weichteilkalzifikation Osteodystrophie (renal bedingt)

IRIS-Stadieneinteilung

relevant ist

Grad d. Azotämie (Messung Kreatininkonzentration)

Grad d. Proteinurie

Grad d. Hypertension

SDMA auch relevant:

(Kreatinin alleine nicht so aussagekräftig -> bei abnehmender Muskelmasse, kann man Nierenfunktion überschätzen)

Stadium II mit SDMA >25 μg/dl -> wie Stadium III

Stadium II mit SDMA >45 μg/dl -> wie Stadium IV

Therapie

!Nach Diagnose regelmäßige Kontrollen, ob Patient gut eingestellt ist!

Proteinurie:

-> Nierendiät + ACE-Hemmer/ Angiotensin-Rez.-Blocker (=RAAS-Inhibitoren) -> Reduktion intraglomerulärer Druck u. GFR !Nie bei HYPOVOLÄMISCHEN Katzen -> Niere kann nicht autoregulieren wg. RAAS-Inhibitoren! Absetzen bei Erbrechen/ Durchfall! -> Medikamente/ RAAS-Inhibitoren: Benazepril, Telmisartan -> wenn Albumin < 20g/l -> Gabe Aspirin/ Clopidogrel

Bluthochdruck (Ziel: Blutdruck zw. 120-160mmHg):

-> Amlodipin (=Kalziumkanalblocker) mit ev. zusätzlich RAAS-Inhibitor

Dehydratation:

-> ad libitum Wasserangebot + Nassfutter, ev. subkutane Flüssigkeitstherapie od. über Sonde

Nierendiät:

-> reduzierter Proteingehalt (-> weniger stickstoffhaltige Abbauprodukte), phosphor- u. natriumarm, kaliumsubstituiert, vorteilhaftes Fettsäuren-Verhältnis !Umstellung nie in akuter Phase -> Futteraversion! -> Bei Bedarf Einsatz von Appetitstimulantien (Mirtazapin, Cyproheptadin) oder legen einer Ernährungssonde

Hyperphosphatämie:

-> alimentäre Phosphorrestriktion + intestinale Phosphorbinder (Aluminiumsalz; Renalzin, Ipakitine, Pronefra)

Anämie (Behandlung wenn Hämatokrit <20%):

-> Bluttransfusion ->Gabe von Darbepoetin -> Eisentherapie

Erbrechen:

-> Antiemetikum (Maropitant) -> Magenschutz (Sucralfat)

Prognose:

je nach IRIS Stadium, viele Patienten leben (wenn sie gut eingestellt sind) noch sehr lange

[redniruscardiocare]

Telmiark-Beta 25 | Metoprolol Succinate Extended Release, Cilnidipine & Telmisartan Tablets

To enquire further contact at: 📞 8725020244, 9888656719 📧 info.monarkbiocare@gmail.com 🌐 redniruscardiocare.com 📍𝐀𝐝𝐝𝐫𝐞𝐬𝐬: Plot No. 201, 1st Floor , HSIIDC, Industrial Estate, Phase 1, Alipur, Barwala Panchkula (HR) 134118 India

[magnetothemagnificent]

[id: infographic titled "Medications that may interact with heat" with seven colored medication bottled-shaped blurbs with different classes of medications for each:

"Antidepressants// SSRIs: Citalopram (Celexa), Escitalopram (Lexapro), Fluoxetine (Prozac), Paroxetine (Paxil, Pexeva), Sertraline (Zoloft)// SNRIs: Desvenlafaxine (Pristiq), Duloxetine (Cymbalta), Levomilnacipran (Fetzima), Venlafaxine (Effexor XR)// TCAs: Amitriptyline"

"Anticholinergics// Benztropine mesylate (Cogentin)// Oxybutynin (Ditropan XL)// Diphenhydramine (Benadryl)// Benztropine (Cogentin)"

"Central Nervous System Stimulants// Armodafininil (Nuvigil)// AtomexitinE (Strattera)// Dextroamphetamine (Adderall, Dexedrine)// Amphetamine (Adderall)// Lisdexamfetamine (Vyvanse)// Methamphetamine (Desoxyn)"

"Heart Medications// Diuretics: Furosemide (Lasix)// ACE inhibitors: Lisinopril, Captopril, Enalapril// ARBs: Candesartan (Atacand), Irbesartan (Avapro), Losartan (Cozaar), Olmesartan (Benicar), Telmisartan (Micardis), Valsartan (Diovan)// Beta Blockers, Calcium Channel Blockers"

"Anti-psychotics// Risperidone// Olanzapine// Quetiapine// Haloperidol"

"Insulin// Heat can damage insulin, making it less effective. // Don't store in a hot place like a car or in direct sunlight"

"Commonly abused substances// Alcohol// Cocaine"

end id.]

Also oral contraceptives can make you more sensitive to the sun, so be careful.

Here's a list of medications listed by Yale Climate Communications in a separate article (link) that may not be as effective in hot weather or that might have adverse effects on your body's ability to adapt to hot weather:

[catonplay]

TAZLOC BETA 50 TABLET 10S

medimny.com is offering TAZLOC BETA 50 TABLET 10S available at affordable Price .

Chemical Combination : {Telmisartan 40 MG +Metoprolol Succinate 50 MG}

Product Category : {Blood Pressure}

Price :-₹124.96 *Excluding GST

For more info: - medimny.com

[advikpharma]

Telmisartan Tablets - High Blood Pressure Management

Advik Pharma's telmisartan pills are made to effectively treat high blood pressure. By facilitating smoother blood flow and lowering the risk of heart attacks and strokes, these medications assist relax blood vessels. If you want dependable and regular blood pressure control, use telmisartan in your hypertension medication regimen. Advik Pharma delivers quality and efficacy with each dosage.

[platinumpharmacy]

Cilacar T Tablet: Uses, Dosage, Side Effects, and More

Cilacar T Tablet is a medication that is commonly prescribed to help manage various cardiovascular conditions. This article aims to provide an in-depth overview of Cilacar T Tablet, including its uses, dosage guidelines, potential side effects, and other essential information for those considering or currently using this medication.

What is Cilacar T Tablet?

Cilacar T Tablet is a combination medication that typically contains two active ingredients: Cilnidipine and Telmisartan. Cilnidipine belongs to the class of calcium channel blockers, while Telmisartan is an angiotensin receptor blocker (ARB). This combination is often prescribed to treat hypertension (high blood pressure) and other cardiovascular conditions.

Uses of Cilacar T Tablet

Hypertension: Cilacar T Tablet is primarily used to lower blood pressure in patients with hypertension. The combination of Cilnidipine and Telmisartan helps relax blood vessels, making it easier for the heart to pump blood and reducing the workload on the heart.

Cardiovascular Protection: In addition to managing high blood pressure, Cilacar T Tablet may also offer cardiovascular protection by reducing the risk of heart-related complications in patients with underlying heart conditions.

Dosage and Administration

Dosage: The dosage of Cilacar T Tablet can vary based on individual factors such as the patient's age, medical condition, and response to treatment. It is crucial to follow the dosage instructions provided by your healthcare provider.

Administration: Cilacar T Tablet is typically taken orally with or without food. It is essential to swallow the tablet whole with a glass of water and not crush or chew it unless advised otherwise by your doctor.

Possible Side Effects

Like any medication, Cilacar T Tablet may cause side effects in some individuals. Common side effects associated with this medication may include:

Dizziness

Headache

Fatigue

Swelling of the ankles or feet

Nausea or vomiting

Muscle pain

It is essential to consult your healthcare provider if you experience any persistent or severe side effects while taking Cilacar T Tablet.

Precautions and Warnings

Before starting Cilacar T Tablet, inform your healthcare provider about any existing medical conditions, allergies, or medications you are currently taking. Additionally, consider the following precautions:

Avoid consuming alcohol while taking Cilacar T Tablet, as it may increase the risk of side effects.

Inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding before using this medication.

Regular monitoring of blood pressure and kidney function may be necessary while taking Cilacar T Tablet.

Conclusion

Cilacar T Tablet is a combination medication used to manage hypertension and provide cardiovascular protection. While it can be effective in controlling blood pressure and reducing the risk of heart-related complications, it is essential to follow your healthcare provider's recommendations regarding dosage, administration, and monitoring. If you experience any concerning side effects or have questions about Cilacar T Tablet, consult your doctor promptly for guidance and appropriate management.